How to Buy Enliven Therapeutics Stock
Enliven Therapeutics Inc
Enliven Therapeutics, Inc. is a biopharmaceutical enterprise, currently in the clinical development phase, dedicated to discovering and advancing small molecule therapeutic agents aimed at combating cancer.
Enliven Therapeutics stock last closed at $54.43, up 0.2% from the previous day, and has increased 194.22% in one year. It has overperformed other stocks in the Biotechnology industry by 2.09 percentage points. Enliven Therapeutics stock is currently +268.14% from its 52-week low of $14.79, and -12.66% from its 52-week high of $62.32.
There are currently 73.27M shares of ELVN outstanding. The market value of ELVN is $3.99B. In the last 24 hours, 858,000 ELVN shares were traded.
How to Buy Enliven Therapeutics Stock
Wondering how to invest in Enliven Therapeutics stock? Here's how.
- Figure out where to buy Enliven Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you choose where to buy Enliven Therapeutics stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit funds into your brokerage account: Select your method of payment and add your details.
- Research Enliven Therapeutics stock: The Enliven Therapeutics ticker symbol is ELVN. Is Enliven Therapeutics stock a good investment? Should you buy shares of ELVN? How do ELVN's underlying business fundamentals look? Do top analysts think Enliven Therapeutics is a good buy? Why has ELVN's stock price moved recently? (Hint: Our stock research website can help you decide if ELVN is a good stock to buy).
- Execute your ELVN buy order: Decide if you will purchase ELVN shares at the current market price or use a limit order to purchase ELVN stock at a specific price.
- Monitor your investment in ELVN: Create a watchlist to the latest updates on your position in Enliven Therapeutics shares.
Step 1: Figure out where to buy Enliven Therapeutics stock
You will need an online brokerage account to access the NASDAQ market and buy ELVN shares.
Our preferred brokerage: eToro
In our opinion, eToro is the best place to buy stocks. Here's why:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global financial markets: From Technology to Industrials, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked the best brokerage, you need to fill out some personal details so you are able to invest in ELVN today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to start your new brokerage account.
- Submit your information by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've finished signing up on our top ranked stock app, you can securely and quickly fund your account:
Watch this video walkthrough to see the process of depositing funds into your investment account.
Step 4: Research Enliven Therapeutics stock
After you have decided on the best place to buy Enliven Therapeutics stock, it's absolutely critical to analyze their stock before you buy, so you truly understand the risk and opportunity.
Enliven Therapeutics quick stats
ELVN Overview
WallStreetZen was created to help average investors do more in-depth fundamental analysis in less time.
You can see all of the due diligence checks on ELVN's stock page.
How is ELVN stock valued?
Analysts use many financial metrics, analyses, models, and charts to gauge ELVN's true value.
Using relative valuations ratios:
- ELVN could be undervalued based on its P/B ratio of 4.46x, relative to Biotechnology industry P/B ratio of 5.35x
You can access additional valuation analysis on ELVN's stock here.
ELVN Financial Health Overview
Passed Health Checks:
- ELVN has cash burn of 66824000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the ELVN balance sheet.
- Total ELVN debt is lower than 5 years ago, relative to shareholder equity.
- ELVN has $895.16M in cash and short term investments. This is enough to cover its annual cash burn of $66.82M.
- There are more short-term assets than short-term liabilities on the ELVN balance sheet.
- ELVN has a low debt to equity ratio of 0.02.
Do Wall Street analysts think it's a good time to buy ELVN stock
Out of 8 Wall Street analysts who monitor ELVN, the consensus analyst rating on ELVN is a Strong Buy
It's important to keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
Latest ELVN Analyst Recommendations
Salveen Richter, a top 19% analyst from Goldman Sachs maintains ELVN with a strong buy rating and raises their ELVN price target from $67.00 to $80.00, on Aug 6, 2026.
Robert Burns, a top 5% analyst from HC Wainwright & Co. maintains ELVN with a buy rating and raises their ELVN price target from $56.00 to $64.00, on Jul 9, 2026.
Boris Peaker, a top 28% analyst from Jones Trading maintains ELVN with a strong buy rating and raises their ELVN price target from $45.00 to $70.00, on Jun 29, 2026.
You can dive deeper into what analysts are saying on the Enliven Therapeutics stock forecast page.
ELVN Trading Indicators
What are ELVN insiders up to?
In the last year, executives and large shareholders at ELVN have sold more shares than they have bought.
Helen Louise Collins, Med of ELVN, was the latest ELVN insider to buy. They bought $12,400.00 worth of ELVN shares on Aug 17, 2026.
Research more about who owns ELVN shares here.
Does ELVN provide a stable income stream?
No, Enliven Therapeutics doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Execute your ELVN buy order
You have two main options:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally the best for newer investors. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a given dollar amount, place a limit order.
Click the Open Trade button and your broker will place your order.
If you need more help investing in stocks on eToro, watch the how to video below:
Step 6: Monitor your investment in ELVN
Now that you own some shares in ELVN, you'll want to keep up with your new investment.
Add ELVN to a watchlist to monitor your ELVN stock.
ELVN Feed
How to Buy Stock in Enliven Therapeutics
To summarize, here are the 6 steps to buy stock in Enliven Therapeutics:
- Figure out where to buy Enliven Therapeutics stock
- Open a brokerage account
- Deposit funds into your brokerage account
- Research Enliven Therapeutics stock
- Execute your ELVN buy order
- Monitor your investment in ELVN
If you require a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get notifications regarding your investment in Enliven Therapeutics, create a watchlist on WallStreetZen today.
More "How To" Guides You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.